This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Eichna, L. W. Articles by IYENGAR, R. Search for Related Content PubMed PubMed Citation Articles by Eichna, L. W. Articles by IYENGAR, R.

(Circulation. 1961;24:471.)
© 1961 American Heart Association, Inc.

---

Cardiac Myosin and Congestive Heart Failure in the Dog

Ludwig W. Eichna M.D.; ROBERT E. OLSON PH.D., M.D.¹; ERIC ELLENBOGEN PH.D.¹; RAJA IYENGAR PH.D.¹

¹ From the Department of Biochemistry and Nutrition, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.

Chronic congestive heart failure has been produced in dogs by surgical induction of valvular disease. Cardiac myosin was isolated from the normal dogs and from dogs with congestive heart failure and characterized. Physicochemical properties of the cardiac myosins were determined by measurements of velocity sedimentation, partial specific volume, rate of diffusion, limiting viscosity number, light-scattering behavior, and ATPase activity. The measurements show that normal cardiac myosin (myosin C) has a molecular weight of 225,000, whereas myosin from the failing heart (myosin F) has a molecular weight of 690,000. This change in molecular weight occurs without a marked alteration in amino acid composition and suggests that end-to-end trimerization of normal cardiac myosin occurs in association with congestive heart failure in the dog. There was no significant change in ATPase activity.